Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.

Autor: Bromberg, Jacoline E C, Issa, Samar, van der Holt, Bronno, van der Meulen, Matthijs, Dirven, Linda, Minnema, Monique C, Seute, Tatjana, Durian, Marc, Cull, Gavin, Poel, Marjolein W M van der, Stevens, Wendy B C, Zijlstra, Josee M, Brandsma, Dieta, Nijland, Marcel, Mason, Kylie D, Beeker, Aart, Abrahamse-Testroote, Martine C J, Bent, Martin J van den, Jong, Daphne de, Doorduijn, Jeanette K
Zdroj: Neuro-Oncology; Apr2024, Vol. 26 Issue 4, p724-734, 11p
Databáze: Complementary Index